FDA considers dropping Avastin approval, approves five-day emergency contraception pi

[News]

The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.

More... (http://www.news-medical.net/news/20100817/FDA-considers-dropping-Avastin-approval-approves-five-day-emergency-contraception-pill.aspx)